Peripheral Artery Disease Market Research Report: By Disease Type (Organic and Functional), Treatment Type (Medications, Angioplasty, Bypass Grafting, Atherectomy, Thrombolytic Therapy and others), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025.Increased global prevalence of artery diseases has fuelled the demand for peripheral artery disease market.Market Research Future (MRFR) in its latest report reveals that the global peripheral artery diseases market will exhibit a healthy CAGR during between 2017 and 2023.Atherosclerosis in associated with hardening of plaque that trigger clot formation in arteries, leading to their blockage.Global demand for peripheral artery disease treatment has grown substantially in recent years.Availability of superior treatment and therapeutics for peripheral artery disease has reflected favourably on the market.Data released by European Federation of Pharmaceutical Industries and Association reveals that in 2016 R investments in the Pharmaceutical Industry reached EUR 35000 Mn.Factors such as influx of fake drug, high risk oh infection and severe side-effects associated with treatment options somewhat derail the market growth.Browse Complete Report : https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540Global Peripheral Artery Disease Market: Segmental Analysis The segment analysis of the market has been conducted based on devices, drugs, and types of diseases.On the basis of devices, the market has been segmented into atherectomy devices, angioplasty balloon catheters, stents and others.
Capnography Market Research Report: Information by Type (Capnograph and Disposable), by Devices (Handheld and Others), by Application (Procedural Sedation, Critical Care, and Others), End-User (Hospitals, Clinics, and Others) – Forecast Till 2027The Global Capnography Market is expected to exhibit a robust 19.5% CAGR over the forecast period from 2018 to 2027, according to the latest research report from Market Research Future (MRFR).The report presents a detailed analysis of the global capnography market by providing readers with a comprehensive overview of the market’s historical trajectory.The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.The study also makes a detailed analysis of the major players operating in the global capnography market and provides a detailed look at the various competitive strategies employed by players in the global capnography market.Capnography was primarily developed for monitoring in anesthesia and intensive care situations.As such, the growing number of surgical procedures is likely to be a key driver for the capnography market over the forecast period.
Market Research Future Published a Half Cooked Research Report on Body Contouring Market Research Report- Forecast To 2023Body Contouring Market Research Report, By Devices (Non-Invasive Devices, Minimally Invasive Devices & Invasive Devices) - Forecast Till 2023Market InsightsBody Contouring Market is a process by which the body part is adjusted or altered to enhance the appearance, which refers to the removal of excess body fat.The increase in the obese population is the main driver of the market.Along with these technological advancements, the enhancement of the most successful surgical treatment has spurred market growth.In addition, the availability of simple payment methods has made it easy to access the procedures for the patients, which contributes to market growth.In addition, technological developments have made these procedures more accurate and efficient, stimulating the market.The growing number of the aging population and the introduction of advanced products by market participants are other market factors.High scale development in healthcare sector specifically in emerging nations is predicted to support the growth of the global market.Moreover, several factors, such as increased disposable income, rising geriatric population, technological progress, and greater aesthetic awareness, should lead to market growth over the forecast period.
E-health services Information, by types (EHR, ePrescribing, Telemedicine, big data systems, Clinical Decision Support, Consumer health IT) by service (Administrative ,Clinical, Financial) by end user (hospitals, clinics and others)-Forecast to 2023Overview:Global E-Health Services Market is expected to reach USD 270 billion in 2023 from USD 120 billion in 2016 with a CAGR of approximately 12.9% during the forecast period 2017-2023.The term eHealth is a kind of umbrella that encompasses information and communications technologies that find substantial traction in the healthcare sector.It can be defined as an emerging field that connects public health, medical informatics, and business.The process aims at providing a connection that not just impacts on a local-scale but involves diverse strata to impact the worldwide market with the assistance of information and communication technology.Several factors like better digitization, easy access to funds, high investment structural revamping, and others are expected to provide the global e-health services market substantial thrust.Segmentation:The study of the global market for e-health services reveals a pattern that includes segments like type and service.Such an extensive study can unfurl insights about the market that can impact the market outcomes in the future.By type, the global market for e-health services includes Clinical Decision Support System (CDSS), Consumer Health IT, Knowledge Management System (KMS), Electronic Health Records (EHR), ePrescribing, big data systems, Telemedicine, and others.By service, the market for e-health services can be segmented into administrative services, clinical services, and financial services.All these segments are expected to mark substantial growth in the coming years.By end user, the market for e-health services comprises health insurance companies, clinics, hospitals, and others.The hospitals segment is making a substantial advantage.Browse Complete Report : https://www.marketresearchfuture.com/reports/e-health-services-market-1252Regional Analysis:By region, the study for e-health services includes regions like the Americas and Europe who are substantially contributing to the global market by fetching in revenues, Asia Pacific (APAC) that is catching up first and the Middle East & Africa (MEA) that would witness steady growth.In the Americas, North America would contribute substantially due to the presence of developed countries like Canada and the US.
Market HighlightsAccording to MRFR analysis, Human Immunodeficiency Virus (HIV) Drugs Market is expected to register a CAGR of 5% during the forecast period of 2019 to 2025 and was valued at USD 24 million in 2018.HIV drugs aim to control the growth of the human immunodeficiency virus (HIV), improve the patient’s overall immune system, and reduce/stop the symptoms.The drugs used to treat HIV infection are antiretrovirals, which help reduce the viral load and fight the infection.The growth of the global HIV drug market is driven by the increasing prevalence of HIV infection, rising awareness of HIV treatment, and the launch of innovative drugs.However, stringent regulatory policies for drug approval and product recalls are expected to curb the growth of the global HIV drug market during the assessment period.The global Human Immunodeficiency Virus (HIV) Drugs Market is currently dominated by several market players.The key players are involved in product launches and strategic collaborations to strengthen their market positions.SegmentationThe global HIV drug market has been segmented based on type and end-user.The market, based on type, has been divided into nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors, CCR5 antagonists, integrase inhibitors, post-attachment inhibitors, and pharmacokinetic enhancers.
Market ForecastRegistering a CAGR of 5.4%, Anxiety Disorder Treatment Market is expected to reach USD 16.96 Million by 2025.People with anxiety disorders may feel anxious most of the time or for the brief, intense episodes, which may occur for no apparent reason.The main categories of anxiety disorders include phobia, panic disorder, generalized anxiety disorder, social anxiety disorder, selective mutism, and separation anxiety disorder.For instance, Eli Lilly and Company launched Duloxetine and Forest Laboratories, Inc. launched Vilazodone, used for the treatment of generalized anxiety disorder.Market InfluencersStrategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major key players are positively influencing the market.Regional AnalysisOn a regional basis, the Americas is anticipated to dominate the global anxiety disorder treatment market owing to the rising incidence of anxiety disorders in the region.
Market HighlightsThe Global Orthopedic Braces Market is expected to cross USD 5.8 Billion by 2025 at a CAGR of 6.1%.Orthopedic Braces Market are devices used to support and strengthen the muscles and joints of the knee, ankle, neck, elbow, back, wrist, hip, and fingers.These braces are designed to provide mechanical strength and support to reduce pain due to sprain, strain, and other musculoskeletal disorders.The growth of the global orthopedic braces market is driven by various factors such as rising geriatric population, rising incidence cases of sports-related injuries among athletes, easy availability of orthopedic braces, growing public awareness related to preventive care, and increasing prevalence of osteoarthritis.However, high patient preference for alternative treatment is expected to curb the growth of the global orthopedic braces market.The global orthopedic braces market is currently dominated by several market players.The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The orthopedic braces market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.The orthopedic braces market in the Middle East & Africa has been divided into the Middle East and Africa.Browse Complete Report :https://www.marketresearchfuture.com/reports/orthopedic-braces-market-8372SegmentationThe global orthopedic braces market has been segmented based on product, type, application, and end user.The market, based on product, has been divided into knee braces, foot and ankle braces, upper extremity braces, and others.
Market HighlightsThe Diabetic Ulcer Treatment Market affects the movement or musculoskeletal systems such as muscles, tendons, and ligaments.These disorders are also known as repetitive motion injuries.They affect different parts of the body, mainly the upper and lower back and neck.The growth of global the diabetic ulcer treatment market is driven by various factors such as increasing global geriatric patient population, rising prevalence, and rising prevalence rate of diabetic foot ulcer patients.The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The diabetic ulcer treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.Due to the increasing patient pool of diabetic ulcer treatment and technological advancements in the healthcare sector, Asia-Pacific is expected to be the fastest-growing.
Contact Lenses Market: Information by Wear Type (Daily Disposable Lenses, Disposable Lenses, Frequent Replacement Lenses and Conventional Lenses), by Type (Corrective Lens, Therapeutic Lenses and Cosmetic and Lifestyle Oriented Lens), by Material (Silicone Hydrogel Soft Contact Lens, Methacrylate Hydrogel Soft Contact Lens, Gas-Permeable Contact Lens and others), by Design (Spherical Lens, Toric Lens, Multifocal Lens and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 The Global Contact Lenses Market is expected to register a CAGR of 5.70% to reach USD 12,330.46 Million by 2025.Contact lenses are a boon for many people, no matter they prefer to wear it while going out, during sports activities, or use them as an alternative to glasses.Different Purposes Contact lenses have different uses- decorative, cosmetic, therapeutic, and optical.Optical lenses are those that are used to correct the vision, therapeutic lenses help in the work of medicines which are used for treating eye conditions, cosmetic lenses help to enhance or change the wearer’s natural eye color and alter the appearance of the eyes, and decorative lenses are colored contacts that are used for fun which comes in various patterns for producing various effects.Glasses Contact lenses provide functional benefits over glasses, especially in areas such as work-in humid climate, sports, and occupations where glasses are not compatible and are inconvenient with the equipment utilized, especially headgears.It moves along with the eyes, and the wearer looks through the lens’s clearest part- the optic zone.This way, they can easily focus on completely enjoying their activity or sport.
Glioblastoma Treatment Market: Information by Type (Primary Glioblastoma and Secondary Glioblastoma), by Treatment (Surgical Procedure, Radiation Therapy, Chemotherapy and others), by End User (Hospitals, Specialty Clinics & Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 Market HighlightsThe Global Glioblastoma Treatment Market is expected to register a CAGR of 7.40% during the forecast period with a market value of USD 1,643.4 Million till 2025.Glioblastoma is a malignant grade IV tumor.The increasing incidence rates, the rise in product approvals, and growing research in the field are projected to drive the growth of the global Glioblastoma Treatment Market.On the other hand, the termination of many clinical trial drug candidates is anticipated to hamper the growth of the market.Segment AnalysisThe global Glioblastoma Treatment Market has been divided based on type, treatment, and end user.The market, based on type, has been segregated into primary glioblastoma and secondary glioblastoma.Based on treatment, the Glioblastoma Treatment Market has been divided into surgical procedure, radiation therapy, chemotherapy, and others.
Clinical Alarm Management Market Research Report: Information by Product (Nurse Call Systems, Physiological Monitors, EMR Integration Systems, Bed Alarms, Ventilators, Mobility Solutions, Central Monitoring Systems, Clinical Decision Support [CDC] Tools and others), Component (Solutions and Services), End-User (Hospitals and Clinics, Long-Term Care (LTC) Centers and Ambulatory Care Centers & Home Care Settings) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025Market SynopsisMarket Research Future (MRFR) proposes that the global Clinical Alarm Management Market is slated to demonstrate 30.4% CAGR during the forecast period (2018-2023).Clinical alarm management devices are developed using different non-invasive technology and software in order to monitor the condition of a patient.These solutions are extensively adopted by the ambulatory surgical centers and hospitals to respond to clinical alarms.They are implemented for some applications and include mobility solutions, clinical decision support tools, alarm auditing software, central monitoring systems, and clinical alarm reporting software.Market Potential and PitfallsThe clinical alarm is an essential solution for proper patient monitoring during critical conditions, the safety of the patients, and alert the healthcare staff regarding changes in a patient’s condition.Clinical alarm management is high in demand in clinics, hospitals, intensive care units, and healthcare facilities owing to the rising awareness regarding patient safety, increasing government mandates regarding the safety of the patients, and surging demand for best practices in healthcare centers and hospitals.The market’s course is chiefly directed by the rising incidences of chronic diseases, need for cost-containment in the healthcare delivery, growth in the geriatric population, and increasing prominence of mHealth tools and big data.On the contrary, sleep disruption caused due to noise, noise fatigue, and an unpleasant environment for the staff, patients, as well as families due to the noise of the alarm are some of the major concerns considered to vitiate the market growth throughout the appraisal period.Additionally, the unstandardized integrated alarm systems are likely to deter the market growth to a large extent.Global Clinical Alarm Management Market: Segmental AnalysisThe global clinical alarm management market has been segmented on the basis of component, product, and end-user.By mode of product, the global clinical alarm management market has been segmented into physiological monitors, nurse call systems, bed alarms, EMR integration systems, mobility solutions, ventilators, clinical decision support tools, and central monitoring systems.
Platelet Aggregation Devices Market Trends And Growth Analysis By Product (Systems, Reagents, Consumables And Accessories), Application (Clinical, Research Applications), End User (Hospitals And Clinics, Diagnostic Laboratories, Others) - Global Forecast Till 2023Market HighlightsThe global Platelet Aggregation Devices Market held a market value of USD 215.2 million in 2017 and is projected to grow at a CAGR of 20.3% over the forecast period.Few of the major market growth factors are the globally growing geriatric population coupled with rising prevalence of target diseases, surging number of industry-academia collaborations and clinical studies, and increasing technological advancements in platelet aggregometers such as 96-well plate-based aggregometry.According to the World Health Organization (WHO), in 2017, the worldwide population aged 60 years and above was 962.0 million, which is projected to increase to more than 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.Regional AnalysisThe global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.This is due to the presence of device manufacturers, rising prevalence of orthopedic, urological, and bleeding disorders, surging number of cardiovascular surgeries, and increasing incidence of blood disorders.For instance, as per the data provided by the National Hemophilia Foundation, currently, hemophilia A occurs in 1 in 5,000 live male births in US which is about four times as common as hemophilia B.SpA, and Haemochrom Diagnostica GmbH and the development of affordable platelet function tests by the manufacturers.The market in Asia-Pacific is expected to register comparatively higher CAGR over the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases and platelet disorders, and rising incidences of mosquito-borne diseases such as malaria and dengue.The Middle East & Africa has the least share of the global platelet aggregation devices market.
Porcine Vaccines Market Research Report: by Type (Inactivated Vaccines, DNA Vaccines), by Disease Indication (Diarrhea, Swine Influenza), By End User - Global Forecast Till 2023Market HighlightsThe Global Porcine Vaccines Market held a market value of USD 1910.7 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period.Porcine vaccines aid the swine or hogs suffering from epidemic swine diseases.It also helps in improving overall efficiency in protecting swine from deadly viruses, bacteria and increases the production level of high-quality meat and gelatine.Additionally, rising number of biotechnology companies, research institutions engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and increasing demand for porcine meat and gelatine are likely to contribute to the market growth.According to National Pork Producers Council the pork production has an estimated USD 23.4 billion of gross output nationwide.However, high cost of maintaining vaccines may hamper the market growth during the assessment period.Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global porcine vaccines market owing to the increasing prevalence of porcine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc.
Sleep Testing Services Market Research Report: by Diagnostic Services (Home Sleep Testing, In-Lab Sleep Testing), by Treatment Monitoring Services (Obstructive Sleep Apnea, Insomnia, Narcolepsy, Others), by End User (Hospitals, Other) - Global Forecast Till 2023 Market HighlightsThe global Sleep Testing Services Market is anticipated to hold a market value of USD 5.9 billion in the year 2017 and is expected to grow at a CAGR of 13.2% during the forecast period.Sleep testing services are used to diagnose sleep disorders by recording heart rate, breathing patterns, brain waves, eye movements, leg movements, etc.Rising prevalence of sleep disorders, increasing awareness about sleep testing services and technological advancements related to sleep testing services are expected to drive the growth in the market over the forecast period.According to an article published in the Psychiatry Research magazine by Science Direct published in July 2018, global prevalence of restless leg syndrome (a sleep disorder) is 14.8%.However, high costs of the sleep testing services can restrain the market growth over the assessment period.Regional AnalysisGeographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services.According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person.Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc.